U.S. Markets closed
  • S&P 500

    4,662.85
    +3.82 (+0.08%)
     
  • Dow 30

    35,911.81
    -201.81 (-0.56%)
     
  • Nasdaq

    14,893.75
    +86.94 (+0.59%)
     
  • Russell 2000

    2,162.46
    +3.02 (+0.14%)
     
  • Crude Oil

    84.27
    +2.15 (+2.62%)
     
  • Gold

    1,817.30
    -4.10 (-0.23%)
     
  • Silver

    22.99
    -0.17 (-0.74%)
     
  • EUR/USD

    1.1416
    -0.0044 (-0.3881%)
     
  • 10-Yr Bond

    1.7720
    +0.0610 (+3.57%)
     
  • Vix

    19.19
    -1.12 (-5.51%)
     
  • GBP/USD

    1.3680
    -0.0030 (-0.2216%)
     
  • USD/JPY

    114.2000
    +0.0200 (+0.0175%)
     
  • BTC-USD

    43,032.02
    -26.25 (-0.06%)
     
  • CMC Crypto 200

    1,037.76
    +12.02 (+1.17%)
     
  • FTSE 100

    7,542.95
    -20.90 (-0.28%)
     
  • Nikkei 225

    28,124.28
    -364.85 (-1.28%)
     

3 Penny Stocks Insiders Are Buying

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Alimera Sciences

The Trade: Alimera Sciences, Inc. (NASDAQ: ALIM) Director James R Largent acquired a total of 10000 shares at an average price of $4.31. The insider spent $43,090.00 to buy those shares.

What’s Happening: The company, last week, posted a wider-than-expected quarterly loss.

What Alimera Sciences Does: Alimera Sciences Inc is a pharmaceutical company focused on commercializing and developing treatments that address diseases affecting the back of the eye (retina).

ServiceSource International

The Trade: ServiceSource International, Inc. (NASDAQ: SREV) 10% owner Jonathan Brolin acquired a total of 240000 shares shares at an average price of $1.30. The insider spent $311,550.00 to buy those shares.

What’s Happening: The company recently reported upbeat quarterly sales.

What ServiceSource International Does: ServiceSource International is a provider of customer and revenue lifecycle management solutions. The firm operates in a single segment which is focused on service offerings that integrate data, processes and cloud technologies.

PHX Minerals

The Trade: PHX Minerals Inc. (NYSE: PHX) 10% owner Jonathan Brolin acquired a total of 12593 shares at an average price of $3.05. To acquire these shares, it cost $38,389.42.

What’s Happening: PHX Minerals recently sold a package of 499 non-operated legacy working interest wellbores located in the Fayetteville Shale of Arkansas to an undisclosed buyer for $2,125,000.

What PHX Minerals Does: PHX Minerals, previously Panhandle Oil & Gas, is an oil and natural gas mineral company that has employed a strategy to shift the core of its business away from drilling and toward perpetual mineral and natural gas ownership.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.